Wellgistics Health Inc (WGRX)
NASDAQ:WGRX
Want to see WGRX full AI Analyst Report?
WGRX Stock Chart & Stats
$0.14
--
Market closed
$0.14
--
Day’s Range― - ―
52-Week Range$0.07 - $2.66
Previous CloseN/A
VolumeN/A
Average Volume (3M)28.82M
Market Cap
$16.08M
Enterprise Value$37.83M
Total Cash (Recent Filing)$51.73K
Total Debt (Recent Filing)$28.73M
Price to Earnings (P/E)―
Beta1.02
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding125,671,250
10 Day Avg. Volume1,367,507
30 Day Avg. Volume28,820,997
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-2.28
Price to Sales (P/S)1.22
P/FCF Ratio-2.61
Enterprise Value/Market Cap2.35
Enterprise Value/Revenue2.70
Enterprise Value/Gross Profit-4.04
Enterprise Value/Ebitda-0.71
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strategic Joint Venture & Patient AccessThe 51% JV with Kare PharmTech creates an integrated MSO/AI hub tying EinsteinRx to Kare's network, providing durable access to provider channels and 200k+ patient lives. This structural distribution and contractual reach can sustain recurring revenue and accelerate DTC and telepharmacy scale over months.
AI + Blockchain Platform ScaleWellgistics' EinsteinRx and PharmacyChain connect thousands of pharmacies and hundreds of manufacturers, creating network effects and data-driven routing advantages. Such entrenched connectivity supports stickier revenue, higher switching costs for partners, and long-term opportunities in hub services and fulfillment.
EBV Preferred Pricing Enables Recurring RevenuePreferred EBV pricing integrated into EinsteinRx addresses a core adoption barrier (coverage verification), opening a durable service revenue line while lowering client costs. EBV is structurally necessary for pharmacy workflow adoption, so exclusive pricing and integration materially improve long-term monetization and platform competitiveness.
Bears Say
Negative Shareholders' Equity & High LeverageNegative equity and substantial debt constrain strategic optionality and raise refinancing risks. Over a multi‑month horizon, this capital-structure weakness limits investment in growth, increases default/forbearance vulnerability, and forces management to prioritize servicing creditors over scaling operations or pursuing longer-term commercialization.
Persistent Cash Burn And Weak Cash GenerationSustained negative operating and free cash flow imply ongoing dependence on external financing. Even with modest FCF improvement, continued cash burn over months pressures liquidity, raises financing costs, and may force dilutive raises or restrictive covenants that impair long-term strategic execution and margin recovery.
Severe Profitability Deterioration And Margin PressureSharp revenue decline paired with deeply negative gross margins signals structural pricing or cost-of-goods issues and an inflated fixed-cost base. Over the coming months, restoring positive unit economics is essential; absent durable gross-margin improvement, scaling revenue will not translate into sustainable profitability or cash generation.
Wellgistics Health Inc News
WGRX FAQ
What was Wellgistics Health Inc’s price range in the past 12 months?
Wellgistics Health Inc lowest stock price was $0.07 and its highest was $2.66 in the past 12 months.
What is Wellgistics Health Inc’s market cap?
Wellgistics Health Inc’s market cap is $16.08M.
When is Wellgistics Health Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Wellgistics Health Inc’s earnings last quarter?
Currently, no data Available
Is Wellgistics Health Inc overvalued?
According to Wall Street analysts Wellgistics Health Inc’s price is currently Overvalued.
Does Wellgistics Health Inc pay dividends?
Wellgistics Health Inc does not currently pay dividends.
What is Wellgistics Health Inc’s EPS estimate?
Wellgistics Health Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wellgistics Health Inc have?
Wellgistics Health Inc has 125,671,250 shares outstanding.
What happened to Wellgistics Health Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Wellgistics Health Inc?
Currently, no hedge funds are holding shares in WGRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Wellgistics Health Inc
Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Technical Analysis
―
Prestige Consumer Healthcare
―
―
Synergy CHC
―
Guardian Pharmacy Services, Inc. Class A
―
Ownership Overview
13.58% Insiders
0.78% Mutual Funds
0.06% Other Institutional Investors
85.14% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---